Search

Your search keyword '"Lee, Samuel"' showing total 216 results

Search Constraints

Start Over You searched for: Author "Lee, Samuel" Remove constraint Author: "Lee, Samuel" Publisher elsevier bv Remove constraint Publisher: elsevier bv
216 results on '"Lee, Samuel"'

Search Results

5. Gut-derived ammonia contributes to alcohol-related fatty liver development via facilitating ethanol metabolism and provoking ATF4-dependent de novo lipogenesis activation

11. How Ophthalmologists Can Decarbonize Eye Care

14. Increased hospital admissions for alcohol-associated hepatitis during the COVID-19 pandemic in Alberta, Canada: a retrospective cohort study

15. Tu1261: IMPACT OF THE COVID-19 PANDEMIC ON THE EPIDEMIOLOGY OF ALCOHOL-ASSOCIATED HEPATITIS

16. Global multi-stakeholder endorsement of the MAFLD definition

17. Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, Canada

23. Novel variant in glycophorin c gene protects against ribavirin-induced anemia during chronic hepatitis C treatment

32. Evaluating the role of transient elastography post chronic hepatitis C treatment to predict hepatocellular carcinoma

33. Integrated Morphoelectric and Transcriptomic Classification of Cortical GABAergic Cells

34. Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19

36. Efficacy of sofosbuvir/velpatasvir (s/v): impact of treatment adherence

43. Toward an Integrated Classification of Cell Types: Morphoelectric and Transcriptomic Characterization of Individual GABAergic Cortical Neurons

46. THU-393-HCV infection in Canadian immigrants: Characteristics and treatment outcomes of the CANUHC cohort

47. FRI-259-Characteristics and sustained virologic response of persons reporting illicit substance use in the past 6 months: Results from the CANUHC prospective patient registry

48. FRI-258-Sustained virologic response among non-cirrhotic persons who inject drugs: Results from the CanHepC retrospective hepatitis C registry

50. Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 or 6 infection (ENDURANCE-5,6): an open-label, multicentre, phase 3b trial

Catalog

Books, media, physical & digital resources